Table 3 Breast cancer odd ratios for BPE quantified separately from three SUBs for 51 women with a cancer diagnosis and 51 controls with a biopsy-proven benign finding.
| Ā | SUB1 | SUB2 | SUB3 | |
|---|---|---|---|---|
Comparison A: Contralateral breasts of both cancer cases and controls | ||||
|BPE| | Univariate | 1.5 (1.1, 2.2); pā=ā0.026 | 1.4 (1.0, 1.8); pā=ā0.025 | 1.3 (1.0, 1.7); pā=ā0.031 |
Multivariable | 2.0 (1.1, 3.7); pā=ā0.021 | 1.9 (1.1, 3.0); pā=ā0.014 | 1.8 (1.1, 2.8); pā=ā0.017 | |
BPE% | Univariate | 3.1 (1.2, 7.9); pā=ā0.018 | 2.5 (1.2, 5.3); pā=ā0.012 | 2.3 (1.1, 4.5); pā=ā0.021 |
Multivariable | 3.5 (1.3, 9.8); pā=ā0.015 | 2.9 (1.3, 6.6); pā=ā0.010 | 2.5 (1.2, 5.1); pā=ā0.015 | |
Comparison B: Benign breast of controls vs contralateral breasts of cancer cases | ||||
|BPE| | Univariate | 1.5 (1.0, 2.1); pā=ā0.037 | 1.4 (1.0, 1.8); pā=ā0.031 | 1.3 (1.0, 1.7); pā=ā0.038 |
Multivariable | 2.3 (1.1, 4.8); pā=ā0.032 | 1.9 (1.1, 3.4); pā=ā0.020 | 1.8 (1.1, 3.1); pā=ā0.028 | |
BPE% | Univariate | 7.0 (1.6, 30.5); pā=ā0.010 | 4.7 (1.6, 13.7); pā=ā0.005 | 3.3 (1.2, 9.1); pā=ā0.023 |
Multivariable | 7.4 (1.6, 35.6); pā=ā0.012 | 5.5 (1.7, 18.4); pā=ā0.005 | 3.5 (1.2, 10.0); pā=ā0.020 | |